Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Fernandez-Martos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Clinically relevant study end points in rectal cancerCarlos Fernandez-Martos, Angel Guerrero, Bruce Minsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancerNuria Ruiz, Carlos Fernandez-Martos, Ignacio Romero, et al.
Clinical Colorectal Cancer|December 17, 2005
FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancerJorge Aparicio, Carlos Fernandez-Martos, Jose M Vincent, et al.
Molecular Cancer|January 20, 2023
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancerKeisuke Okuno, Raju Kandimalla, Marta Mendiola, et al.
Cancers|December 9, 2020
Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized TrialsMaria C Riesco-Martinez, Carlos Fernandez-Martos, Cristina Gravalos-Castro, et al.
Gastroenterologia Y Hepatologia|December 20, 2011
[Hepatic cyst in a patient with anorectal cloacogenic carcinoma: metastasis or benign liver disease?]Isidro Machado, Jesús Santos, Ana Calatrava, et al.
Journal of Clinical Medicine|June 2, 2021
Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRTMeritxell Molla, Julen Fernandez-Plana, Santiago Albiol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
The Oncologist|September 12, 2014
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter TrialCarlos Fernandez-Martos, Gina Brown, Rafael Estevan, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 7, 2012
Clinically relevant study end points in rectal cancerCarlos Fernandez-Martos, Angel Guerrero, Bruce Minsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancerNuria Ruiz, Carlos Fernandez-Martos, Ignacio Romero, et al.
Clinical Colorectal Cancer|December 17, 2005
FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancerJorge Aparicio, Carlos Fernandez-Martos, Jose M Vincent, et al.
Molecular Cancer|January 20, 2023
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancerKeisuke Okuno, Raju Kandimalla, Marta Mendiola, et al.
Cancers|December 9, 2020
Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized TrialsMaria C Riesco-Martinez, Carlos Fernandez-Martos, Cristina Gravalos-Castro, et al.
Gastroenterologia Y Hepatologia|December 20, 2011
[Hepatic cyst in a patient with anorectal cloacogenic carcinoma: metastasis or benign liver disease?]Isidro Machado, Jesús Santos, Ana Calatrava, et al.
Journal of Clinical Medicine|June 2, 2021
Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRTMeritxell Molla, Julen Fernandez-Plana, Santiago Albiol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
The Oncologist|September 12, 2014
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter TrialCarlos Fernandez-Martos, Gina Brown, Rafael Estevan, et al.
Journal of the National Cancer Institute|July 5, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402David Pesántez, Sanne Ten Hoorn, Isidro Machado, et al.
Pageof 2